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osting by EAbstract Background and aim: Patients with diabetes mellitus are at increased risk for cardiovas-
cular diseases. Cardiovascular autonomic neuropathy (CAN) is a serious complication of diabetes,
as it can contribute in the pathogenesis of diabetic cardiomyopathy (DCM) and has been weakly
linked with left ventricular diastolic dysfunction. Our aim was to investigate the effect of presence
or absence of cardiovascular autonomic neuropathy (CAN) on systolic and diastolic LV function in
normotensive type 1 diabetic patients by using both conventional and tissue Doppler echocardiog-
raphy.
Subjects and methods: Fifty two type 1 diabetic patients entered this study. They were divided into
two groups. The ﬁrst group included 24 patients with evidence of cardiovascular autonomic neurop-
athy. The second group included 28 patients without evidence of cardiovascular autonomic neurop-
athy. In addition to 18 healthy normal weights non diabetic subjects as a control group. Complete
clinical examination, routine laboratory investigations, lipid proﬁle, urinary albumin excretion,
HbA1c and 12 leads ECG were done to all participants. Conventional and tissue Doppler indices
of systolic and diastolic left ventricular function were recorded.oo.com (A.A. Wafa).
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8 M. Ghonem et al.Results: Heart rate was signiﬁcantly higher in diabetic patients with CAN compared to both
diabetic patients without CAN and normal control subjects (P< 0.001, <0.001, respectively). Gly-
cemic control as assessed by HbA1c was more worse in diabetic patients with CAN compare to
diabetic patients without CAN (P< 0.001). As regard conventional echo-Doppler, there were a sig-
niﬁcant difference in A wave velocity and E/A ratio in diabetic patients with or without CAN com-
pared to control (P< 0.001, <0.001, <0.001, <0.001, respectively). Tissue Doppler indices show
a signiﬁcant difference at the lateral annular side in Em and Am velocity and Em/Am ratio in dia-
betic patients with or without CAN vs. control (P< 0.001, <0.001, <0.001, <0.05, <0.05,
<0.01, respectively) and also, between diabetic patients with CAN vs. diabetic patients without
CAN (P< 0.001, <0.05, <0.01, respectively). Also, tissue Doppler indices show a signiﬁcant dif-
ference at the septal annular side in Em and Am velocity and Em/Am ratio in diabetic patients with
or without CAN vs. control (P< 0.001, <0.001, <0.001, <0.01, <0.05, <0.05, respectively) and
also, between diabetic patients with CAN vs. diabetic patients without CAN (P< 0.001, <0.05,
<0.01, respectively). Contrary to that, no signiﬁcant differences were found in LV systolic function
parameters measured by either conventional or tissue Doppler imaging among the three groups.
Conclusion: Our results demonstrated that, LV diastolic function was impaired in normotensive
type 1 diabetic patients and, the presence of CAN is associated with more deterioration in diastolic
function. Systolic function is seems to be unaffected. TDI should be the preferred modality in eval-
uation of LV function as it can detect minimal changes in diastolic function much earlier than con-
ventional echo-Doppler.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Patients with diabetes mellitus are at increased risk for cardio-
vascular diseases.1–4 Diabetes mellitus can affect cardiac struc-
ture and function in the absence of changes in blood pressure
and coronary artery disease, a condition called diabetic cardio-
myopathy (DCM),5–7 which is characterized by diastolic dys-
function, that usually precede the development of systolic
dysfunction.8–12 In addition, some studies using tissue Doppler
imaging (TDI) also support the presence of subtle systolic
abnormalities in diabetics.13 Recently, cardiovascular auto-
nomic neuropathy (CAN) has been weakly linked with LV dia-
stolic dysfunction.14 Tissue Doppler imaging (TDI) has been
evolved as the most sensitive tool for quantitative assessment
of both regional and global left ventricular (LV) systolic and
diastolic function.15,16 In the present study we aimed to inves-
tigate the effect of presence or absence of cardiovascular auto-
nomic neuropathy (CAN) on left ventricular (LV) systolic and
diastolic function in normotensive type 1 diabetic patients
using both conventional and tissue Doppler echocardiography.
2. Subjects and methods
Fifty two type 1 diabetic patients were enrolled in this study.
They were recruited from the attendants of Diabetes Clinic
at Specialized Medical Hospital of Mansoura University. All
of them were treated with insulin alone. Patients were divided
into two groups. The ﬁrst group included 24 patients with evi-
dence of cardiovascular autonomic neuropathy (mean age
33.6 ± 7.8 years). The second group included 28 patients with-
out evidence of cardiovascular autonomic neuropathy (mean
age 31.9 ± 8.6 years). In addition to 18 healthy normal weight
non diabetic subjects as a control group (mean age
31.8 ± 9.5 years). The three groups were of matched age,
sex, and body mass index. All participants were subjected to
through history taking, complete clinical examination, routine
laboratory investigations and 12 leads resting ECG. Diagnoses
of diabetic neuropathy were based on the presence of one ormore distal symmetrical neuropathic symptoms, absence of
ankle or knee reﬂexes and abnormal vibration sense. Cardio-
vascular autonomic neuropathy was deﬁned as loss or de-
creased of heart rate variability during deep inspiration with
beat to beat variation of R–R interval assessed by expira-
tion-to-inspiration (E/I) ratio less than 1.04, or postural hypo-
tension with a fall in systolic blood pressure P20 mmHg.17,18
Hypertension is deﬁned as blood pressure P140/90 or current
antihypertensive medications. Patients with overt nephropathy
(urinary albumin excretion > 300 mg/24 h urine collection),
arterial hypertension, or a history or clinical evidence of
coronary heart disease, cerebrovascular, renal or hepatic
impairment were excluded from the study.
2.1. Echocardiography
All patients were examined at rest in supine and left lateral decu-
bitus positions. Studies were performed using GE (vivid 3 pro)
NORWAY. All two-dimensional, M-mode and Doppler echo-
cardiographic examination were performed using a 2.5 MHZ
phased array transducer. Echocardiographic examination was
done using standard views and techniques according to the
guidelines of American Society of Echocardiography.19
2.2. M-mode and two-dimensional echocardiography
In order to measure the left ventricular dimensions and wall
thickness. LVEF and LVFS were determined in the M-mode
at parasternal short axis as an index of LV systolic function.20
Two-dimensional study done with special emphasis on seg-
mental wall motion abnormalities and atrial dimensions (right
and left).
2.3. Conventional Doppler echocardiography
Pulsed wave Doppler (PWD) was done to measure the mitral
inﬂow velocities, early rapid ﬁlling wave (E) and late ﬁlling
wave (A) by placing the sample volume between the tips of
Figure 2 PWD–TDI of septal side of the mitral annulus showing
decrease Ea velocity in patient with DM with CAN.
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of E wave (DT-E) and the ratio of early to late peak velocity
(E/A) were also calculated.20 Continuous wave Doppler
(CWD) used to measure iso-volumic relaxation time (IVRT)
which is deﬁned as a time period (in milliseconds) between aor-
tic valve closure and mitral valve opening.
2.4. Tissue Doppler echocardiography (TDE)
Pulsed wave tissue Doppler systolic (Sa) and diastolic (early Ea
and late Aa) velocities (cm/s) were obtained from lateral and
septal sides of the mitral valve annulus. Ratio of transmitral
early diastolic velocity and mitral annular early diastolic veloc-
ity (E/Ea) have been developed to noninvasively estimate LV
ﬁlling pressure. We included an example of PWD-TDI of the
septal side of mitral annulus showing Ea velocity which was
normal (12 cm/s) in a control subject (Fig. 1) but decreased
in a diabetic patient with CAN (Fig. 2).21
2.5. Sample collection
All blood samples were taken after an overnight fasting period
of 12 h. A venous blood sample was withdrawn into plain
tube. One ml of withdrawn blood was delivered into EDTA
tube (1 mg/ml blood) for estimation of glycosylated hemoglo-
bin (HbA1c) by fast ion exchange resin separation supplied by
Human Germany. Clear non haemolysed sera were separated
and divided into aliquots. Lipid proﬁle was assessed using
commercially available kits supplied by human (Germany).
Low density lipoprotein cholesterol (LDL-C) was calculated
according to Friedewald22 equation: LDL-C = T. choles-
terol  (TG/5 + HDL-C). Urinary albumin excretion (mg/
24 h urine collection) was measured using immunoturbimetric
assay supplied from Randox Laboratories Ltd. (Diamond
Road, Camlin, UK).
2.6. Statistical methods
Statistical analysis of data was done by using SPSS program
‘‘statistical package for social science’’. The parametric data
were presented in the form of mean and standard deviation
(M± SD). T-test was used for comparison of quantitative
data of two groups. For comparison between qualitative data,Figure 1 PWD–TDI of septal side of the mitral annulus showing
normal Ea velocity (12 cm/s) in a control person.Chi-square test was used. Pearson correlation coefﬁcient was
done to study relation between different items. Signiﬁcance
was considered when P value equal to or less than 0.05 (60.05).
3. Results
No signiﬁcant differences were found as regard age, sex, dura-
tion of diabetes, systolic and diastolic blood pressure, serum
creatinine and urinary albumin excretion in both groups of
type 1 diabetes with or without CAN (Tables 1 and 2). Heart
rate was signiﬁcantly higher in diabetic patients with CAN
compared to both diabetic patients without CAN and normal
control subjects (p< 0.001, <0.001, respectively), however,
no signiﬁcant difference in heart rate were found between dia-
betic patients without CAN and normal control subjects (Ta-
ble 1). Serum triglyceride were signiﬁcantly higher and serum
HDL-cholesterol were signiﬁcantly lower in both groups of
type 1 diabetes with or without CAN compared to control
(P< 0.05, <0.05, 0.01, <0.05, respectively), however, no sig-
niﬁcant difference were found in serum triglycerides, total,
HDL and LDL cholesterol in diabetics with CAN vs. diabetics
without CAN (Table 2). Also, Glycemic control as assessed by
HbA1c was worse in both groups of type 1 diabetes compared
to normal control subjects, and more worse in diabetic patients
with CAN compared to diabetic patients without CAN
(p< 0.0001, <0.0001, <0.001, respectively) (Table 2).
There were a signiﬁcant difference in some conventional
echo parameters as, A wave velocity and E/A ratio in diabetic
patients with CAN vs. control (P< 0.001, <0.001, respec-
tively), and also, in diabetic patients without CAN compared
to control (P< 0.001, <0.001, respectively). Whereas, no sig-
niﬁcant difference in conventional echo-Doppler parameters
were found between diabetics with CAN vs. diabetics without
CAN (Table 3).
There were a signiﬁcant difference in tissue Doppler indices
at the lateral annular side in Em and Am velocity and Em/Am
ratio in diabetic patients with CAN vs. control (P< 0.001,
<0.001, <0.001, respectively), and in diabetic patients
without CAN vs. control (P< 0.05, <0.05, <0.01, respec-
tively) and also, between diabetic patients with CAN vs. dia-
betic patients without CAN (P< 0.001, <0.05, <0.01,
respectively) (Table 4). Also, there were a signiﬁcant difference
in tissue Doppler indices at the septal annular side in Em and
Table 1 Clinical data in diabetic patients with or without CAN and normal control subjects.
Type 1 diabetic patients
with CAN (n= 24)
Type 1 diabetic patients
without CAN (n= 28)
Normal control (n= 18) P value
Sex (F/M) 11/13 (45.8%) 13/15 (46.4%) 8/10 (44.4%) P1 = NS
P2 = NS
P3 = NS
Age (years) 33.6 ± 7.8 31.9 ± 8.6 31.8 ± 9.5 P1 = NS
P2 = NS
P3 = NS
Duration of diabetes (years) 17.2 ± 5.9 15.8 ± 6.9 – NS
Heart rate (b/m) 84.8 ± 7.4 76.1 ± 5.2 74.0 ± 4.0 P1 < 0.001
P2 = NS
P3 < 0.001
SBP (mmHg) 128.2 ± 10.3 126.7 ± 8.9 125.6 ± 9.1 P1 = NS
P2 = NS
P3 = NS
DBP (mmHg) 79.2 ± 8.1 81.0 ± 6.9 80.0 ± 7.3 P1 = NS
P2 = NS
P3 = NS
NS = non signiﬁcant.
P1 for comparison between diabetic subjects with CAN vs. normal control.
P2 for comparison between diabetic subjects without CAN vs. normal control.
P3 for comparison between diabetic subjects with CAN vs. diabetics without CAN.
Table 2 Biochemical data in diabetic patients with or without CAN and normal control subjects.
Type 1 diabetic patients
ic>n = 24)
Type 1 diabetic patients
without CAN (n= 28)
Normal control (n= 18) P value
HbA1c (%) 7.90 ± 0.80 7.20 ± 0.60 4.80 ± 0.25 P1 < 0.0001
P2 < 0.0001
P3 < 0.001
Urinary albumin excretion (mg/24 h urine) 29.9 ± 9.3 29.7 ± 8.9 – NS
Plasma creatinine (mg/dl) 1.03 ± 0.17 1.06 ± 0.12 0.99 ± 0.14 P1 = NS
P2 = NS
P3 = NS
T-cholesterol (mg/dl) 182.4 ± 38.9 177.7 ± 36.7 171.9 ± 29.5 P1 = NS
P2 = NS
P3 = NS
LDL-cholesterol (mg/dl) 108.3 ± 22.8 103.1 ± 22.7 95.5 ± 20.9 P1 = NS
P2 = NS
P3 = NS
HDL-cholesterol (mg/dl) 45.8 ± 8.7 46.8 ± 8.1 52.6 ± 8.9 P1 < 0.01
P2 < 0.05
P3 = NS
Triglyceride (mg/dl) 141.5 ± 35.6 138.9 ± 36.7 118.8 ± 24.1 P1 < 0.05
P2 < 0.05
P3 = NS
NS = non signiﬁcant.
P1 for comparison between diabetic subjects with CAN vs. normal control.
P2 for comparison between diabetic subjects without CAN vs. normal control.
P3 for comparison between diabetic subjects with CAN vs. diabetics without CAN.
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vs. control (P< 0.001, <0.001, <0.001, respectively), and in
diabetic patients without CAN vs. control (P< 0.01, <0.05,
<0.05, respectively) and also, between diabetic patients with
CAN vs. diabetic patients without CAN (P< 0.001, <0.05,
<0.01, respectively) (Table 4). Contrary to that, no signiﬁcant
differences were found in LV systolic function parametersmeasured by either conventional or tissue Doppler imaging
among the three groups (Tables 3 and 4).
4. Discussion
Several investigators have shown abnormal LV diastolic func-
tion in the majority of type 1 diabetic patients,10,23–29 whereas
Table 3 Comparative analysis of conventional Doppler trans-mitral ﬂow measurements and EF in studied groups.
Variable Type 1 diabetic patients
with CAN (n= 24)
Type 1 diabetic patients
without CAN (n= 28)
Normal control
(n= 18)
P value
Ejection fraction (%) 69.2 ± 6.30 70.2 ± 6.11 68.9 ± 6.51 P1 = NS
P2 = NS
P3 = NS
E wave (m/s) 0.82 ± 0.85 0.84 ± 0.01 0.84 ± 0.13 P1 = NS
P2 = NS
P3 = NS
A wave (m/s) 0.74 ± 0.78 0.68 ± 0.16 0.54 ± 0.10 P1 < 0.001
P2 < 0.001
P3 = NS
E/A ratio 1.19 ± 0.29 1.28 ± 0.21 1.59 ± 0.98 P1 < 0.001
P2 < 0.001
P3 = NS
DT-E (ms) 178.68 ± 16.21 180.07 ± 16.81 184.5 ± 18.22 P1 = NS
P2 = NS
P3 = NS
IVRT (ms) 81.25 ± 9.61 81.80 ± 9.20 83.01 ± 11.21 P1 = NS
P2 = NS
P3 = NS
E= early diastolic ﬁlling velocity; CAN= cardiovascular autonomic neuropathy.
A = late diastolic ﬁlling velocity; IVRT = iso-volumic relaxation time.
m/s = meter/second.
DT-E = deceleration time of E wave; NS = non signiﬁcant; msec = millisecond.
P1 for comparison between diabetic subjects with CAN vs. control.
P2 for comparison between diabetic subjects without CAN vs. control.
P3 for comparison between diabetic subjects with CAN vs. diabetics without CAN.
Table 4 Comparative analysis of PW-TDI of mitral annular velocities (cm/s) at the lateral and septal annular sides in studied groups.
Variable Type 1 diabetic patients
with CAN (n= 24)
Type 1 diabetic patients
without CAN (n= 28)
Normal control
(n= 18)
P value
Lateral
Sm (cm/s) 7.31 ± 1.46 7.51 ± 1.70 7.62 ± 1.82 P1 = NS
P2 = NS
P3 = NS
Em (cm/s) 8.40 ± 2.11 11.10 ± 2.01 12.92 ± 1.98 P1 < 0.001
P2 < 0.05
P3 < 0.001
Am (cm/s) 7.33 ± 1.50 6.20 ± 1.55 5.22 ± 1.46 P1 < 0.001
P2 < 0.05
P3 < 0.05
Em/Am 1.21 ± 0.52 1.72 ± 0.51 2.39 ± 0.70 P1 < 0.001
P2 < 0.01
P3 < 0.01
Septal
Sm (cm/s) 7.25 ± 1.40 7.38 ± 1.45 7.60 ± 1.51 P1 = NS
P2 = NS
P3 = NS
Em (cm/s) 8.40 ± 1.21 10.81 ± 1.49 12.27 ± 1.38 P1 < 0.001
P2 < 0.01
P3 < 0.001
Am (cm/s) 7.29 ± 1.64 6.10 ± 1.52 5.01 ± 1.20 P1 < 0.001
P2 < 0.05
P3 < 0.05
Em/Am 1.10 ± 0.52 1.60 ± 0.61 2.11 ± 0.80 P1 < 0.001
P2 < 0.05
P3 < 0.01
Sm= peak mitral systolic velocity; Em= early mitral annular diastolic velocity.
Am= late mitral annular diastolic velocity; PW-TDI = pulsed wave-tissue Doppler imaging.
P1 for comparison between diabetic subjects with CAN vs. control.
P2 for comparison between diabetic subjects without CAN vs. control.
P3 for comparison between diabetic subjects with vs. diabetics without CAN.
Effect of cardiovascular autonomic neuropathy (CAN) on left ventricular function 11
12 M. Ghonem et al.others found no evidence of LV diastolic dysfunction at rest in
long term uncomplicated type 1 diabetic patients.30–32 Also,
some studies have reported decline in ejection fraction,28 and
presence of subtle systolic abnormalities in uncomplicated type
1 diabetic patients,13 whereas others have reported normal LV
systolic function at rest in most type 1 diabetic patients.8
Cardiovascular autonomic neuropathy (CAN) is a serious
complications of diabetes, and can contribute in the pathogen-
esis of diabetic cardiomyopathy through different mechanisms,
as alteration in myocardial blood ﬂow,33 and sympathetic
denervation,34 and through changes in myocardial neurotrans-
mitters.35 It can occur as early as within a year of diagnosis in
type 2 diabetic patients and within 2 years in type 1 diabetic
patients,14,36 and has a signiﬁcant negative impact on survival
and quality of life in people with diabetes.37 Recently, CAN
have been weakly linked with LV diastolic dysfunction,14 how-
ever, many of the studies that have explored the association be-
tween CAN and cardiac dysfunction have mainly used either
conventional echo-Doppler,38 or nuclear techniques to investi-
gate LV diastolic function.39
In the present study, we use both conventional and tissue
Doppler imaging to investigate the effect of presence or ab-
sence of cardiovascular autonomic neuropathy (CAN) on
LV systolic and diastolic function in normotensive uncompli-
cated type 1 diabetic patients and also in normal control sub-
jects. Although, we found a signiﬁcant diastolic dysfunction
in both groups of type 1 diabetic patients compared to nor-
mal control subjects, a more and further impairment in dia-
stolic function were observed in patients with type 1
diabetes with CAN compared with type 1 diabetic patients
without CAN. On the contrary, LV systolic function in type
1 diabetic subjects seems to be unimpaired compared with
normal control subjects, irrespective of the presence or ab-
sence of CAN. This ﬁnding of early diastolic dysfunction is
in accordance with the hypotheses of increased both myocar-
dial stiffness and resting myocyte tension due to deposition of
advanced glycated end products associated with diabetic
cardiomyopathy.40
Also, we found that the signiﬁcant difference in LV dia-
stolic dysfunction between the two groups of type 1 diabetic
subjects was not detected by conventional echo Doppler and
identiﬁed only with tissue Doppler imaging (TDI). Therefore,
compared with conventional echocardiographic approaches
in the evaluation of LV function in diabetic patients, TDI seem
to be the preferred modality in evaluation of LV function, as it
is more sensitive and less dependent on confounders such as
preload or respiratory variation.29
Our results are consistent with the results obtained from a
tissue Doppler study by Karamitsos et al.29 In another study
using conventional echocardiography, it had been described
that, type 1 diabetic patients with CAN exhibit greater left ven-
tricular hypertrophy and more diastolic dysfunction compared
to type 1 diabetic patients without CAN.38 Also, in a study
using a radionuclide ventriculography, it had been reported
that, at rest, patients with CAN have more deterioration of
LV ﬁlling pattern, slightly increased LV systolic function,
and a higher LV working load, in comparison to non-CAN
type 1 diabetic patients.39 In addition, more recently, it has
been reported that cardiovascular autonomic neuropathy is
associated with increased arterial stiffness and decreased myo-
cardial perfusion in childhood-onset type 1 diabetes
population.41Contrary to our results, and also, by using tissue Doppler
imaging, Konduracka et al.,32 concluded that patients with
type 1 diabetes under intensive insulin treatment do not have
echocardiographic, biochemical, or morphological signs of
diabetic cardiomyopathy even in the presence of CAN. Also,
although Humpert et al. found a decrease in LV ejection frac-
tion with decreasing autonomic function, they reported that
there were no difference in diastolic function among diabetic
patients with or without cardiovascular autonomic
neuropathy.42
In the present study, we found that both heart rate and
HbA1c were signiﬁcantly higher in diabetic patients with
CAN compared to diabetics without CAN. However, no sig-
niﬁcant differences were found as regard age of the patients,
duration of diabetes, systolic and diastolic blood pressure, ser-
um creatinine, urinary albumin excretion or lipid proﬁle in
both groups of type 1 diabetes with or without CAN denoting
that these factors did not inﬂuence our results, and make us to
suggest that, the further deterioration in LV diastolic function
could be attributed to the presence of CAN.
In conclusion, our results demonstrated that, LV diastolic
function was impaired in normotensive type 1 diabetic patients
and, the presence of CAN seems to have an additive negative
effect as it is associated with more deterioration in diastolic
function independently of age of the patients and duration of
diabetes. Systolic function is seems to be unaffected. TDI
should be the preferred modality in evaluation of LV function
as it is more sensitive and can detect minimal changes in dia-
stolic function much earlier than conventional echo-Doppler.
Finally, we can recommend that, tight glycemic control,
earlier detection of CAN and regular assessment of cardiac
function using tissue Doppler imaging may be a way for the
prevention of DCM, with consequent improvement of survival
and quality of life of patients with diabetes.
References
1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity
and mortality in diabetics in the Framingham population: sixteen
year follow-up study. Diabetes 1974;23:105–11.
2. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in
congestive heart failure: the Framingham study. Am J Cardiol
1974;34:29–34.
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the
Framingham study. JAMA 1979;241:2035–8.
4. Nathan DM. Long term complications of diabetes mellitus. N
Engl J Med 1993;328:1676–85.
5. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW,
Grishman A. New type of cardiomyopathy associated with
diabetic glomerulosclerosis. Am J Cardiol 1972;30(6):595–602.
6. FeinFS.Diabetic cardiomyopathy.DiabetesCare 1990;13:1169–79.
7. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc
Drugs Ther 1994;8:65–73.
8. Raev DC. Which left ventricular function is impaired earlier in the
evolution of diabetic cardiomyopathy? An echocardiographic
study of young type I diabetic patients. Diabetes Care
1994;17(7):633–9.
9. Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV,
et al. The impact of diabetes on left ventricular ﬁlling pattern in
normotensive and hypertensive adults: the strong heart study. J
Am Coll Cardiol 2001;37:1943–9.
10. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer
BE. Left ventricular diastolic dysfunction as an early manifesta-
tion of diabetic cardiomyopathy. Cardiology 2002;98:33–9.
Effect of cardiovascular autonomic neuropathy (CAN) on left ventricular function 1311. Bell DS. Diabetic cardiomyopathy. Diabetes Care
2003;26:2949–51.
12. Shivalkar B, Dhondt D, Goovaerts I, Van Gaal L, Bartunek J,
Van Crombrugge P, et al. Flow mediated dilatation and cardiac
function in type 1 diabetes mellitus. Am J Cardiol 2006;97:77–82.
13. Fang ZY, Leano R, Marwick TH. Relationship between longitu-
dinal and radial contractility in subclinical diabetic heart disease.
Clin Sci (Lond) 2004;106:53–60.
14. Debono M, Cachia E. The impact of cardiovascular autonomic
neuropathy in diabetes: is it associated with left ventricular
dysfunction? Auton Neurosci 2007;132:1–7.
15. Gorcsan J, Gulati VK, Mandarino WA, Katz WE. Color-coded
measures of myocardial velocity throughout the cardiac cycle by
tissue Doppler imaging to quantify regional left ventricular
function. Am Heart J 1996;131:1203–13.
16. Yu CM, Lin H, Ho PC, Yang H. Assessment of left and right
ventricular systolic and diastolic synchronicity in normal subjects
by tissue Doppler echocardiography and the effects of age and
heart rate. Echocardiography 2003;20:19–27.
17. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prog-
nosis, diagnosis and treatment. Diabetes Metab Rev
1994;10:339–83.
18. Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P,
et al. Assessment of cardiovascular autonomic function: age-
related normal ranges and reproducibility of spectral analysis
vector analysis and standard tests of heart rate variation and blood
pressure responses. Diabetes Med 1992;9:166–75.
19. Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/
ACEP/ASNC/SCAI/SCCT/ SCMR 2007 appropriateness criteria
for transthoracic and transesophageal echocardiography. J Am
Coll Cardiol 2007;50:187–204.
20. Rakowski H, Appleton C, Chan KL, et al. Canadian consensus
recommendations for the measurement and reporting of diastolic
dysfunction by echocardiography: from the Investigators of
Consensus on Diastolic Dysfunction by Echocardiography. J
Am Soc Echocardiogr 1996;9:736–60.
21. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones
MA. Doppler tissue imaging: a noninvasive technique for evalu-
ation of left ventricular relaxation and estimation of ﬁlling
pressures. J Am Coll Cardiol 1997;30:1527–33.
22. Friedewald WT, Levy RI, Friedrickson DS. Estimation of the
concentration of low density lipoprotein cholesterol without the
use of the preparative ultracentrifuge. Clin Chem 1972;18–499.
23. Hausdorf G, Rieger U, Koepp P. Cardiomyopathy in childhood
diabetes mellitus: incidence, time of onset, and relation to
metabolic control. Int J Cardiol 1988;19:225–36.
24. Uusitupa M, Mustonen J, Laakso M, Vainio P, Lansimies E,
Talwar S, et al. Impairment of diastolic function in middle-aged
type I and type II diabetic patients free of cardiovascular disease.
Diabetologia 1988;31:783–91.
25. Paillole C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R.
Prevalence and signiﬁcance of left ventricular ﬁlling abnormalities
determined by Doppler echocardiography in young type I (insulin
dependent) diabetic patients. Am J Cardiol 1989;64:1010–6.
26. Zarich S, Arbuckle B, Cohen L, Roberts M, Nesto R. Diastolic
abnormalities in young asymptomatic diabetic patients assessed by
pulsed Doppler echocardiography. J Am Coll Cardiol
1988;12:114–20.
27. Attali JR, Sachs RN, Valensi P, Palsky D, Tellier P, Vulpillat M,
et al. Asymptomatic diabetic cardiomyopathy: a non-invasive
study. Diabetes Res Clin Pract 1988;4:183–90.28. Carugo S, Giannattasio C, Calchera I, Paleari F, Gorgoglione
A, Grappiolo A, et al. Progression of functional and structural
cardiac alterations in young normotensive uncomplicated patients
with type 1 diabetes mellitus. J Hypertens 2001;19:1675–80.
29. Karamitsos TD, Karvounis HI, Didangellos TP, Karamitsos DT,
Parharidis GE. Impact of autonomic neuropathy on left ventric-
ular function in normotensive type 1 diabetic patients. Diabetes
Care 2008;31:325–7.
30. Salazar J, Rivas A, Rodriguez M, Felipe J, Garcia MD, Bone J.
Left ventricular function determined by Doppler echocardiogra-
phy in adolescents with type I (insulin-dependent) diabetes
mellitus. Acta Cardiol 1994;49:435–9.
31. Romanens M, Fankhauser S, Saner B, Michaud L, Saner H. No
evidence for systolic or diastolic left ventricular dysfunction at rest
in selected patients with long-term type I diabetes mellitus. Eur J
Heart Failure 1999;1:169–75.
32. Konduracka E, Gackawski A, Rostoff P, et al. Diabetes-speciﬁc
cardiomyopathy in type 1 diabetes mellitus: no evidence for its
occurrence in the era of intensive insulin therapy. Eur Heart J
2007;28:2465–71.
33. DiCarli MF, Bianco-Batlles D, Landa ME. Effects of autonomic
neuropathy on coronary blood ﬂow in patients with diabetes
mellitus. Circulation 1999;100:813–9.
34. Hartmann F, Ziegler S, Nekolla S, Hadamitzky M, Seyfarth M,
Richardt G, et al. Regional patterns of myocardial sympathetic
denervation in dilated cardiomyopathy: an analysis using carbon-
11 hydroxyephedrine and positron emission tomography. Heart
1999;81:262–70.
35. Uekita K, Tobise K, Onodera S. Enhancement of the cardiac b-
adrenergic system at an early diabetic state in spontaneously
diabetic Chinese hamsters. Jpn Circ J 1997;61:64–73.
36. Pfeifer MA, Weinberg CR, Cook DL. Autonomic neural dys-
function in recently diagnosed diabetic subjects. Diabetes Care
1984;7:47–453.
37. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic
autonomic neuropathy. Diabetes Care 2003;26:1553–79.
38. Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T,
Larsson HB, Jensen GB, et al. Left ventricular dysfunction in
normotensive type 1 diabetic patients: the impact of autonomic
neuropathy. Diabetes Med 2004;21:524–30.
39. Didangelos TP, Arsos GA, Karamitsos DT, Athyros VG, Karat-
zas ND. Left ventricular systolic and diastolic function in
normotensive type 1 diabetic patients with or without autonomic
neuropathy: a radionuclide ventriculography study. Diabetes Care
2003;26:1955–60.
40. Van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I,
Musters RJ, Kupreishvili K. Diastolic stiffness of the failing
diabetic heart: importance of ﬁbrosis, advanced glycation end
products, and myocyte resting tension. Circulation
2008;117:43–51.
41. Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA,
Orchard TJ. Cardiovascular autonomic neuropathy HDL-choles-
terol and smoking correlate with arterial stiffness markers deter-
mined 18 years later in type 1 diabetes. Diabetes Care March
2010;33(3).
42. Humpert PM, Oikonomou D, Morcos M. Impact of autonomic
neuropathy on left ventricular function in normotensive type 1
diabetic patients: a tissue Doppler echocardiographic study
(letter). Diabetes Care 2008;31:e40. doi:10.2337/dc07-2431.
